The pharmacological profile of brain liver intestine Na+ channel: inhibition by diarylamidines and activation by fenamates.
about
In silico determination of the effect of multi-target drugs on calcium dynamics signaling network underlying sea urchin spermatozoa motilityThe bile acid-sensitive ion channel (BASIC) is activated by alterations of its membrane environmentFlufenamic acid as an ion channel modulator.The comprehensive analysis of DEG/ENaC subunits in Hydra reveals a large variety of peptide-gated channels, potentially involved in neuromuscular transmission.Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activitiesStructure-activity relationship of fenamates as Slo2.1 channel activators.Inhibition of neuronal degenerin/epithelial Na+ channels by the multiple sclerosis drug 4-aminopyridine.Novel diuretic targetsThe bile acid-sensitive ion channel (BASIC), the ignored cousin of ASICs and ENaCStrong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid.Pharmacological and electrophysiological characterization of the human bile acid-sensitive ion channel (hBASIC).Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain.Bile acids increase the activity of the epithelial Na+ channel.A Cytosolic Amphiphilic α-Helix Controls the Activity of the Bile Acid-sensitive Ion Channel (BASIC).Molecular basis of inhibition of acid sensing ion channel 1A by diminazene.
P2860
Q28542568-9BA525AC-C296-4965-8E14-1A218FD734D0Q33359356-0454AB84-DB08-4B2A-B030-4CD39A4E3667Q33978847-52C1C8E7-F067-4CAE-A63F-7E5352A0C683Q34416680-D0DB0814-12F1-40D9-96E2-7BAE1E8FF050Q36142192-DF37C54B-E398-4166-ACA2-D1C29D56DBC9Q36335587-CF66EADF-8CD8-46CD-8A4F-44BA981AC245Q36725102-C2B90E35-B368-4EE7-BDE8-34EFAEE618C2Q37234799-D16A5B57-B424-45BF-AD5B-0943C37A06B3Q38173627-821CE14D-F5EC-4E66-B8AF-7CA606E5594DQ41566502-68C82EBC-76B6-4234-A798-33437CD292D8Q48031105-8422E35D-E2BF-41F8-83F1-2A210A3966ECQ48310094-0494DB01-893F-4BBC-881D-6B50CE881C7EQ48613593-D4586666-7FDD-4021-A0A4-8BE74422A7CCQ50319271-2F63CB6C-B02B-4F32-A810-F5D9D8AABE6CQ55109882-3D8BF116-E20D-43B2-AA98-09E5A79FC504
P2860
The pharmacological profile of brain liver intestine Na+ channel: inhibition by diarylamidines and activation by fenamates.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The pharmacological profile of ...... s and activation by fenamates.
@en
The pharmacological profile of ...... s and activation by fenamates.
@nl
type
label
The pharmacological profile of ...... s and activation by fenamates.
@en
The pharmacological profile of ...... s and activation by fenamates.
@nl
prefLabel
The pharmacological profile of ...... s and activation by fenamates.
@en
The pharmacological profile of ...... s and activation by fenamates.
@nl
P356
P1476
The pharmacological profile of ...... s and activation by fenamates.
@en
P2093
Dominik Wiemuth
P304
P356
10.1124/MOL.111.073726
P577
2011-08-09T00:00:00Z